Cargando…

Deletion of Placental Growth Factor Prevents Diabetic Retinopathy and Is Associated With Akt Activation and HIF1α-VEGF Pathway Inhibition. Diabetes 2015;64:200–212

Detalles Bibliográficos
Autores principales:	Huang, Hu, He, Jianbo, Johnson, Da’Kuawn, Wei, Yanhong, Liu, Ying, Wang, Shuang, Lutty, Gerard A., Duh, Elia J., Semba, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2015
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876739/ https://www.ncbi.nlm.nih.gov/pubmed/25713201 http://dx.doi.org/10.2337/db15-er03

Ejemplares similares

Deletion of Placental Growth Factor Prevents Diabetic Retinopathy and Is Associated With Akt Activation and HIF1α-VEGF Pathway Inhibition
por: Huang, Hu, et al.
Publicado: (2015)

Erratum. Exercise Effects on White Adipose Tissue: Beiging and Metabolic Adaptations. Diabetes 2015;64:2361–2368
por: Stanford, Kristin I., et al.
Publicado: (2015)

Comment on Nolan et al. Insulin Resistance as a Physiological Defense Against Metabolic Stress: Implications for the Management of Subsets of Type 2 Diabetes. Diabetes 2015;64:673–686
por: Taegtmeyer, Heinrich, et al.
Publicado: (2015)

Erratum. PD-L1–Driven Tolerance Protects Neurogenin3-Induced Islet Neogenesis to Reverse Established Type 1 Diabetes in NOD Mice. Diabetes 2015;64:529—540
por: Li, Rongying, et al.
Publicado: (2015)

Response to Comment on Smith et al. Protein Ingestion Induces Muscle Insulin Resistance Independent of Leucine-Mediated mTOR Activation. Diabetes 2015;64:1555–1563
por: Smith, Gordon I., et al.
Publicado: (2015)

Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:2609–2623
por: Khan, Mohd. Parvez, et al.
Publicado: (2017)

Expression Pattern of HIF-1α and VEGF Supports Circumferential Application of Scatter Laser for Proliferative Sickle Retinopathy
por: Rodrigues, Murilo, et al.
Publicado: (2016)

Targeting VEGF in canine oxygen-induced retinopathy – a model for human retinopathy of prematurity
por: McLeod, D Scott, et al.
Publicado: (2016)

Diabetic Retinopathy and VEGF
por: Gupta, N, et al.
Publicado: (2013)

Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α
por: Han, Xiao-Xia, et al.
Publicado: (2012)

Placental Malaria: Hypertension, VEGF, and Prolactin
por: Pearson, Roy Douglas
Publicado: (2007)

Effect of intermittent hypoxia on the cardiac HIF-1/VEGF pathway in experimental type 1 diabetes mellitus
por: Güzel, Derya, et al.
Publicado: (2016)

Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
por: Javanmard, Shaghayegh Haghjooy, et al.
Publicado: (2012)

Regulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGF
por: Schipani, Ernestina, et al.
Publicado: (2009)

VEGF Secreted by Hypoxic Müller Cells Induces MMP-2 Expression and Activity in Endothelial Cells to Promote Retinal Neovascularization in Proliferative Diabetic Retinopathy
por: Rodrigues, Murilo, et al.
Publicado: (2013)

ERK5 Contributes to VEGF Alteration in Diabetic Retinopathy
por: Wu, Yuexiu, et al.
Publicado: (2010)

Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
por: Lai, Meihua, et al.
Publicado: (2023)

Dysregulated Serum Lipid Metabolism Promotes the Occurrence and Development of Diabetic Retinopathy Associated With Upregulated Circulating Levels of VEGF-A, VEGF-D, and PlGF
por: Zhang, Xinyuan, et al.
Publicado: (2021)

Diabetic Retinopathy: A Position Statement by the American Diabetes Association
por: Solomon, Sharon D., et al.
Publicado: (2017)

Local Injection of Deferoxamine Improves Neovascularization in Ischemic Diabetic Random Flap by Increasing HIF-1α and VEGF Expression
por: Wang, Chen, et al.
Publicado: (2014)

Anti-VEGF therapy prevents Müller intracellular edema by decreasing VEGF-A in diabetic retinopathy
por: Wang, Tianqin, et al.
Publicado: (2021)

Search of ligands suitable for (212)Pb/(212)Bi in vivo generators
por: Bartoś, Barbara, et al.
Publicado: (2012)

The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy
por: Kuiper, Esther J., et al.
Publicado: (2008)

VEGF-targeting drugs for the treatment of retinal neovascularization in diabetic retinopathy
por: Arrigo, Alessandro, et al.
Publicado: (2022)

Erratum. 2016 Presidential Address: Diabetes at 212°—Confronting the Invisible Disease. Diabetes Care 2016;39:1657–1663
por: Schatz, Desmond
Publicado: (2017)

Polymorphisms in HIF-1a gene are not associated with diabetic retinopathy in China
por: Liu, Yue-Hong, et al.
Publicado: (2021)

The Role of HIF1α-PFKFB3 Pathway in Diabetic Retinopathy
por: Min, Jie, et al.
Publicado: (2021)

Berberine improves insulin-induced diabetic retinopathy through exclusively suppressing Akt/mTOR-mediated HIF-1α/VEGF activation in retina endothelial cells
por: Wang, Ning, et al.
Publicado: (2021)

A review on the effect of garlic on diabetes, BDNF, and VEGF as a potential treatment for diabetic retinopathy
por: Sanie-Jahromi, Fatemeh, et al.
Publicado: (2023)

Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase
por: Yum, Soohwan, et al.
Publicado: (2017)

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418
por: Solomon, Sharon D., et al.
Publicado: (2017)

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418
por: Solomon, Sharon D., et al.
Publicado: (2017)

Effect of serum cytokines and VEGF levels on diabetic retinopathy and macular thickness
por: Ozturk, Banu Turgut, et al.
Publicado: (2009)

Association of VEGF Gene Polymorphisms with Diabetic Retinopathy: A Meta-Analysis
por: Gong, Jian-Yang, et al.
Publicado: (2013)

Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy
por: Bolinger, Mark T., et al.
Publicado: (2016)

Pro- and antiangiogenic VEGF and its receptor status for the severity of diabetic retinopathy
por: Paine, Suman K., et al.
Publicado: (2017)

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy
por: Bunge, Casey C., et al.
Publicado: (2023)

MiR-212-3p promotes proliferation and migration of trophoblast in fetal growth restriction by targeting placental growth factor
por: Yu, Limin, et al.
Publicado: (2021)

Association study of HIF-1α rs11549465 and VEGF rs3025039 genetic variants with diabetic retinopathy in Egyptian patients: crosslinks with angiogenic, inflammatory, and anti-inflammatory markers
por: Mohamed, Mahmoud K., et al.
Publicado: (2022)

Expression of VEGF, its receptors, and HIF-1α in Dupuytren’s disease
por: Holzer, Lukas A, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0e5sl7h6kbhiaafokm12c69r1u